Rainbow Childrens Medicare Reports Mixed Financial Results Amid Growth and Rising Costs
Rainbow Childrens Medicare has announced its financial results for the quarter ending December 2024, showcasing a mixed performance. While net sales and profit before tax have seen significant growth, the company faces challenges with rising interest costs and a declining debtors turnover ratio, raising concerns about financial sustainability.
Rainbow Childrens Medicare has recently reported its financial results for the quarter ending December 2024, revealing a mixed performance landscape. The company, operating within the Hospital & Healthcare Services industry, has experienced notable growth in certain areas while facing challenges in others.On the positive side, Rainbow Childrens Medicare reported net sales of Rs 815.54 crore for the half-year, reflecting a year-on-year growth of 21.97%. Additionally, the profit before tax (PBT) for the quarter stood at Rs 81.06 crore, marking a 21.0% increase compared to the average PBT of the previous four quarters. These figures suggest a favorable near-term sales and profit trend.
Conversely, the company is grappling with rising interest costs, with interest expenses reaching Rs 54.33 crore, indicating increased borrowings. Furthermore, the debtors turnover ratio has declined to 15.02 times, the lowest in the last five half-yearly periods, suggesting a slowdown in the pace of settling debts. Lastly, non-operating income has peaked at Rs 13.27 crore, raising concerns about the sustainability of this income source.
In light of these developments, Rainbow Childrens Medicare has undergone an adjustment in its evaluation.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
